UoH granted patent for HIV drug combination efficacy enhancers
The Hindu
The University of Hyderabad (UoH) has been granted to patent “High active antiretroviral combination drugs loaded lactoferrin nanoparticles for first line and second line therapy” for targeted deliver
The University of Hyderabad (UoH) has been granted to patent “High active antiretroviral combination drugs loaded lactoferrin nanoparticles for first line and second line therapy” for targeted delivery of a combination of antiretroviral drugs to HIV-1 infected cells.
This has been developed in the laboratory for molecular therapeutics, Department of Biotechnology and Bioinformatics, School of Life Sciences, under the supervision of Anand K. Kondapi, a statement said.
The patented technology produces lactoferrin nanoparticles encapsulated in a combination of drugs in first line or second line therapy as a single drug product in an oral capsule for treatment of HIV-1.
Around 440 MBBS graduates of 2021 are not required to undergo one year of compulsory rural service as per the bond signed by them while joining the medical course through government-quota seats in 2015 as the High Court of Karnataka has said the law, enacted in 2012 for mandatory rural service, remained unenforced for 10 years as it was published in the official gazette only in July 2022.